Epidemiology of invasive fungal infections in neonates and children

Clinical Microbiology and Infection

Volumn 16, Issue 9, 2010, Pages 1321-1327

  Steinbach, W J ^a,b,c  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c International Pediatric Fungal Network   (United States)

Author keywords

Antifungal; Aspergillosis; Candidiasis; Fungal infection; Paediatric; Review

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ECHINOCANDIN; FLUCONAZOLE; VORICONAZOLE;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIFUNGAL SUSCEPTIBILITY; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; ASPERGILLUS TERREUS; AUTOPSY; BIRTH WEIGHT; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDEMIA; CANDIDURIA; CLINICAL TRIAL; DRUG USE; FUNGAL COLONIZATION; GESTATIONAL AGE; HIGH RISK POPULATION; HUMAN; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED PATIENT; INCIDENCE; INVASIVE ASPERGILLOSIS; INVASIVE CANDIDIASIS; LENGTH OF STAY; LUNG ASPERGILLOSIS; LUNG CAVITATION; MORBIDITY; MORTALITY; MYCOSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SKIN INFECTION; THROMBOCYTOPENIA;

EID: 77956121299     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03288.x     Document Type: Review

References (57)

1. Neofytos D, Horn D, Anaissie E. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 2009, 48:265-273.
2. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999, 29:239-244.
3. Chayakulkeeree M, Perfect JR. Cryptococcosis. Infect Dis Clin North Am 2006, 20:507-544.
4. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002, 34:909-917.
5. McNeil MM, Nash SL, Hajjeh RA. Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis 2001, 33:641-647.
6. Talbot GH, Bradley J, Edwards JE, Gilbert D, Scheld M, Bartlett JG. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 2006, 42:657-668.
7. Pappas PG, Rotstein CM, Betts RF. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. Clin Infect Dis 2007, 45:883-893.
8. Bicanic T, Meintjes G, Wood R. Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole. Clin Infect Dis 2007, 45:76-80.
9. Herbrecht R, Denning DW, Patterson TF. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002, 347:408-415.
10. Maertens J, Raad I, Petrikkos G. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis 2004, 39:1563-1571.
11. Wilson LS, Reyes CM, Stolpman M, Speckman J, Allen K, Beney J. The direct cost and incidence of systemic fungal infections. Value Heath 2002, 5:26-34.
12. Johnson MD, Kleinberg M, Danziger L, Ostrosky-Zeichner L. Pharmacoeconomics of antifungal pharmacotherapy-challenges and future directions. Expert Opin Pharmacother 2005, 6:2617-2632.
13. Challa S, Prayaga AK, Vemu L. Fungal endocarditis: an autopsy study. Asian Cardiovasc Thorac Ann 2004, 12:95-98.
14. Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996, 33:23-32.
15. Kume H, Yamazaki T, Abe M, Tanuma H, Okudaira M, Okayasu I. Increase in aspergillosis and severe mycotic infection in patients with leukemia and MDS: comparison of the data from the Annual of the Pathological Autopsy Cases in Japan in 1989, 1993 and 1997. Pathol Int 2003, 53:744-750.
16. Tharayil John G, Shankar V, Talaulikar G. Epidemiology of systemic mycoses among renal-transplant recipients in India. Transplantation 2003, 75:1544-1551.
17. de Medeiros BC, de Medeiros CR, Werner B. Central nervous system infections following bone marrow transplantation: an autopsy report of 27 cases. J Hematother Stem Cell Res 2000, 9:535-540.
18. van Burik JH, Leisenring W, Myerson D. The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis. An autopsy study of 355 patients. Medicine (Baltimore) 1998, 77:246-254.
19. Kontoyiannis DP, Marr KA, Park BJ. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010, 50:1091-1100.
20. Burgos A, Zaoutis TE, Dvorak CC. Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases. Pediatrics 2008, 121:e1286-e1294.
21. Groll AH, Kurz M, Schneider W. Five-year-survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long-term survival. Mycoses 1999, 42:431-442.
22. Crassard N, Hadden H, Piens MA. Invasive aspergillosis in a paediatric haematology department: a 15-year review. Mycoses 2008, 51:109-116.
23. Zaoutis TE, Heydon K, Chu JH, Walsh TJ, Steinbach WJ. Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000. Pediatrics 2006, 117:e711-e716.
24. Wisplinghoff H, Seifert H, Tallent SM, Bischoff T, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities. Pediatr Infect Dis J 2003, 22:686-691.
25. Pfaller MA, Diekema DJ, Jones RN, Messer SA, Hollis RJ. Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000. J Clin Microbiol 2002, 40:852-856.
26. Diekema DJ, Messer SA, Brueggemann AB. Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol 2002, 40:1298-1302.
27. Benjamin DKJ, DeLong ER, Steinbach WJ, Cotton CM, Walsh TJ, Clark RH. Empirical therapy for neonatal candidemia in very low birth weight infants. Pediatrics 2003, 112:543-547.
28. Benjamin DKJ, Poole C, Steinbach WJ, Rowen JL, Walsh TJ. Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques. Pediatrics 2003, 112(3 Pt 1):634-640.
29. Robinson JL, Davies HD, Barton M. Characteristics and outcome of infants with candiduria in neonatal intensive care-a Paediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study. BMC Infect Dis 2009, 23:183-193.
30. Benjamin DKJ, Stoll BJ, Fanaroff AA. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 2006, 117:84-92.
31. Noyola DE, Bohra L, Paysse EA, Fernandez M, Coats DK. Association of candidemia and retinopathy of prematurity in very low birthweight infants. Ophtalmology 2002, 109:80-84.
32. Roilides E, Farmaki E, Evdoridou J. Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates. Eur J Clin Microbiol Infect Dis 2004, 23:745-750.
33. Farmaki E, Evdoridou J, Pouliou T. Fungal colonization in the neonatal intensive care unit: risk factors, drug susceptibility, and association with invasive fungal infections. Am J Perinatol 2007, 24:127-135.
34. Manzoni P, Farina D, Leonessa M. Risk factors for progression to invasive fungal infection in preterm neonates with fungal colonization. Pediatrics 2006, 118:2359-2364.
35. Perfect JR, Cox GM, Lee JY. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 2001, 33:1824-1833.
36. Abbasi S, Shenep JL, Hughes WT, Flynn PM. Aspergillosis in children with cancer: a 34-year experience. Clin Infect Dis 1999, 29:1210-1219.
37. Walmsley S, Devi S, King S, Schneider R, Richardson S, Ford-Jones L. Invasive Aspergillus infections in a pediatric hospital: a ten-year review. Pediatr Infect Dis J 1993, 12:673-682.
38. Herbrecht R, Auvrignon A, Andres E. Efficacy of amphotericin B lipid complex in the treatment of invasive fungal infections in immunosuppressed paediatric patients. Eur J Clin Microbiol Infect Dis 2001, 20:77-82.
39. Nosari A, Oreste P, Cairoli R. Invasive aspergillosis in haematological malignancies: clinical findings and management for intensive chemotherapy completion. Am J Hematol 2001, 68:231-236.
40. Vonberg RP, Gastmeier P. Nosocomial aspergillosis in outbreak settings. J Hosp Infect 2006, 63:246-254.
41. Steinbach WJ, Walsh TJ. Mycoses in pediatric patients. Infect Dis Clin North Am 2006, 20:663-678.
42. Caillot D, Casasnovas O, Bernard A. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997, 15:139-147.
43. Gefter WB, Albelda SM, Talbot GH, Gerson SL, Cassileth PA, Miller WT. Invasive pulmonary aspergillosis and acute leukemia. Limitations in the diagnostic utility of the air crescent sign. Radiology 1985, 157:605-610.
44. Thomas KE, Owens CM, Veys PA, Novelli V, Costoli V. The radiological spectrum of invasive aspergillosis in children: a 10-year review. Pediatr Radiol 2003, 33:453-460.
45. Taccone A, Occhi M, Garaventa A, Manfredini L, Viscoli C. CT of invasive pulmonary aspergillosis in children with cancer. Pediatr Radiol 1993, 23:177-180.
46. Krupova Y, Sejnova D, Dzatkova J. Prospective study on fungemia in children with cancer: analysis of 35 cases and comparison with 130 fungemias in adults. Supportive Care Cancer 2000, 8:427-430.
47. Allan BT, Patton D, Ramsey NKC, Day DL. Pulmonary fungal infections after bone marrow transplantation. Pediatr Radiol 1988, 18:118-122.
48. Sulahian A, Tabouret M, Ribaud P. Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosis. Eur J Clin Microbiol Infect Dis 1996, 15:139-145.
49. Herbrecht R, Letscher-Bru V, Oprea C. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 2002, 7:1898-1906.
50. Steinbach WJ, Addison RM, McLaughlin L. Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients. Pediatr Infect Dis J 2007, 26:558-564.
51. Hayden R, Pounds S, Knapp K. Galactomannan antigenemia in pediatric oncology patients with invasive aspergillosis. Pediatr Infect Dis J 2008, 27:815-819.
52. Verweij PE, Weemaes CM, Curfs JHAJ, Bretagne S, Meis JFG. Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis. J Clin Microbiol 2000, 38:3900-3901.
53. Smith PB, Benjamin DKJ, Alexander BD, Johnson MD, Finkelman MA, Steinbach WJ. Quantification of 1,3-beta-D-glucan levels in children: preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting. Clin Vaccine Immunol 2007, 14:924-925.
54. Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 2005, 41:1232-1239.
55. Zaoutis TE, Greves HM, Lautenbach E, Bilker WB, Coffin SE. Risk factors for disseminated candidiasis in children with candidemia. Pediatr Infect Dis J 2004, 23:635-641.
56. Pappas PG, Kauffman CA, Andes D. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:503-535.
57. Reboli AC, Rotstein C, Pappas PG. Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med 2007, 356:2472-2482.